Literature DB >> 2870290

Totally implantable vascular access in treatment of cystic fibrosis.

J Pattison, D P Heaf.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2870290     DOI： 10.1016/s0140-6736(86)91806-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

1.  Thrombolysis for indwelling catheter related thrombosis and superior vena cava obstruction in cystic fibrosis: a case series.

Authors:  T Hassan; S H Chotirmall; T B Low; M G Flynn; N G McElvaney; C Gunaratnam
Journal:  Ir J Med Sci       Date:  2010-06-19       Impact factor: 1.568

2.  Thromboembolism related to a Port-a-Cath device in a patient with cystic fibrosis.

Authors:  B Yung; J S Elborn; I A Campbell; Y Summers; M Beckles; A A Woodcock
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

3.  Transverse myelitis: a reversible complication of bronchial artery embolisation in cystic fibrosis.

Authors:  K L Fraser; H Grosman; R H Hyland; D E Tullis
Journal:  Thorax       Date:  1997-01       Impact factor: 9.139

4.  Totally implantable venous access devices - 20 years' experience of implantation in cystic fibrosis patients.

Authors:  T James Royle; Ruth E Davies; Mark X Gannon
Journal:  Ann R Coll Surg Engl       Date:  2008-11       Impact factor: 1.891

5.  Totally implantable venous access devices in children with cystic fibrosis: incidence and type of complications.

Authors:  J Deerojanawong; S M Sawyer; A M Fink; K B Stokes; C F Robertson
Journal:  Thorax       Date:  1998-04       Impact factor: 9.139

Review 6.  Increased vigilance needed for the detection of thrombotic complications of central venous access in adolescent cystic fibrosis patients.

Authors:  Nandini Kandamany; Basil Elnazir; Peter Greally
Journal:  Front Pediatr       Date:  2014-11-19       Impact factor: 3.418
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.